Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Valvular Heart Disease

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 49 articles: HTML format

Single Articles

September 2022
1. KAPADIA SR, Makkar R, Leon M, Abdel-Wahab M, et al
   Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement.
   N Engl J Med. 2022 Sep 17. doi: 10.1056/NEJMoa2204961.
   PubMed     Abstract available
   
   
   May 2022
2. GAMMIE JS, Hung J, Ailawadi G
   Tricuspid Repair in Patients with Degenerative Mitral Regurgitation. Reply.
   N Engl J Med. 2022;386:1862-1863.
   PubMed    
   
   
   
3. TOMSIC A, Palmen M, Klautz RJM
   Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.
   N Engl J Med. 2022;386:1862.
   PubMed    
   
   
   
4. GUPTA R, Gerges F, Gupta N
   Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.
   N Engl J Med. 2022;386:1861-1862.
   PubMed    
   
   
   
5. BELLUMKONDA L
   Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.
   N Engl J Med. 2022;386:1861.
   PubMed    
   
   
   April 2022
6. MATZA MA, Rincon SP, Yucel E, Jorge AM, et al
   Case 12-2022: A 41-Year-Old Woman with Transient Ischemic Attack and Mitral Valve Masses.
   N Engl J Med. 2022;386:1560-1570.
   PubMed    
   
   
   
7. AIKAWA E, Hutcheson JD
   The Developmental Origin of Calcific Aortic Stenosis.
   N Engl J Med. 2022;386:1372-1374.
   PubMed    
   
   
   November 2021
8. CHIKWE J, Gaudino M
   The Price of Freedom from Tricuspid Regurgitation.
   N Engl J Med. 2021 Nov 13. doi: 10.1056/NEJMe2116776.
   PubMed    
   
   
   
9. GAMMIE JS, Chu MWA, Falk V, Overbey JR, et al
   Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.
   N Engl J Med. 2021 Nov 13. doi: 10.1056/NEJMoa2115961.
   PubMed     Abstract available
   
   
   July 2021
10. VARELA DL, Jones TL
    Perivalvular Abscess Causing Coronary-Artery Compression.
    N Engl J Med. 2021;385:e3.
    PubMed    
    
    
    March 2021
11. BERWANGER O, Guimaraes HP, Lopes RD
    Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve. Reply.
    N Engl J Med. 2021;384:975-976.
    PubMed    
    
    
    
12. DURAES AR, Bitar YSL
    Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
    N Engl J Med. 2021;384:975.
    PubMed    
    
    
    
13. ALGHAMRY A, Lee JC
    Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
    N Engl J Med. 2021;384:974-975.
    PubMed    
    
    
    
14. LOTLIKAR A, Anwar S
    Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
    N Engl J Med. 2021;384:974.
    PubMed    
    
    
    
15. VERMA A, Dhingra N, Yanagawa B
    Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
    N Engl J Med. 2021;384:973-974.
    PubMed    
    
    
    January 2021
16. BROUWER J, Nijenhuis VJ, Ten Berg JM
    Single or Dual Antiplatelet Treatment after TAVI. Reply.
    N Engl J Med. 2021;384:90-91.
    PubMed    
    
    
    
17. FAHRNI G, Jeger R, Mueller C
    Single or Dual Antiplatelet Treatment after TAVI.
    N Engl J Med. 2021;384:90.
    PubMed    
    
    
    
18. EIKELBOOM R, Belley-Cote EP, Whitlock RP
    Single or Dual Antiplatelet Treatment after TAVI.
    N Engl J Med. 2021;384:90.
    PubMed    
    
    
    
19. ANWAR S, Spence E, Zawadka M
    Single or Dual Antiplatelet Treatment after TAVI.
    N Engl J Med. 2021;384:89-90.
    PubMed    
    
    
    November 2020
20. GUIMARAES HP, Lopes RD, de Barros E Silva PGM, Liporace IL, et al
    Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
    N Engl J Med. 2020 Nov 14. doi: 10.1056/NEJMoa2029603.
    PubMed     Abstract available
    
    
    October 2020
21. CORTAZAR FB, Rhee EP, Gupta S, Sakhuja R, et al
    Case 34-2020: A 74-Year-Old Man with Chronic Kidney Disease.
    N Engl J Med. 2020;383:1768-1778.
    PubMed    
    
    
    
22. O'GARA PT, Mack MJ
    Secondary Mitral Regurgitation.
    N Engl J Med. 2020;383:1458-1467.
    PubMed    
    
    
    August 2020
23. BROUWER J, Nijenhuis VJ, Delewi R, Hermanides RS, et al
    Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.
    N Engl J Med. 2020 Aug 30. doi: 10.1056/NEJMoa2017815.
    PubMed     Abstract available
    
    
    
24. VAN BELLE E, Labreuche J, Vincent F
    Five-Year Outcomes with Transcatheter Aortic-Valve Replacement. Reply.
    N Engl J Med. 2020;383:596.
    PubMed    
    
    
    
25. MAKKAR RR, Mack MJ, Leon MB
    Five-Year Outcomes with Transcatheter Aortic-Valve Replacement. Reply.
    N Engl J Med. 2020;383:595-596.
    PubMed    
    
    
    
26. KHOKHAR AA, Giannini F, Colombo A
    Five-Year Outcomes with Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2020;383:594-595.
    PubMed    
    
    
    
27. BARILI F, Freemantle N, Parolari A
    Five-Year Outcomes with Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2020;383:594.
    PubMed    
    
    
    July 2020
28. DANGAS GD, De Backer O, Windecker S
    A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. Reply.
    N Engl J Med. 2020;383:e8.
    PubMed    
    
    
    
29. ALGHAMRY A, Murdoch DJ
    A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2020;383:e8.
    PubMed    
    
    
    
30. STOJKOVIC S, Sulzgruber P, Niessner A
    A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2020;383:e8.
    PubMed    
    
    
    
31. YAHAGI K, Sato Y, Virmani R
    A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2020;383:e8.
    PubMed    
    
    
    
32. MARTIN AC, Smadja DM, Karam N
    A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2020;383:e8.
    PubMed    
    
    
    
33. KANG DH, Park SW
    Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis. Reply.
    N Engl J Med. 2020;383:92-93.
    PubMed    
    
    
    
34. SIDEBOTHAM D, Morrow CD, Drake DH
    Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis.
    N Engl J Med. 2020;383:92.
    PubMed    
    
    
    
35. GARRY JD, Goldman M, Kohlwes J
    Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis.
    N Engl J Med. 2020;383:91-92.
    PubMed    
    
    
    April 2020
36. FEIT F
    How Un-POPular Is Bleeding in Patients with TAVI?
    N Engl J Med. 2020;382:1761-1763.
    PubMed    
    
    
    March 2020
37. NIJENHUIS VJ, Brouwer J, Delewi R, Hermanides RS, et al
    Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.
    N Engl J Med. 2020 Mar 29. doi: 10.1056/NEJMoa1915152.
    PubMed     Abstract available
    
    
    February 2020
38. MAKKAR RR, Thourani VH, Mack MJ, Kodali SK, et al
    Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement.
    N Engl J Med. 2020;382.
    PubMed     Abstract available
    
    
    January 2020
39. KANG DH, Park SJ, Lee SA, Lee S, et al
    Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis.
    N Engl J Med. 2020;382.
    PubMed     Abstract available
    
    
    
40. LANCELLOTTI P, Vannan MA
    Timing of Intervention in Aortic Stenosis.
    N Engl J Med. 2020;382.
    PubMed    
    
    
    
41. NISHIMURA RA, Holmes DR Jr
    Treatment after TAVR - Discordance and Clinical Implications.
    N Engl J Med. 2020;382:193-194.
    PubMed    
    
    
    November 2019
42. FAROOQUI FA, Deepti S
    Myxomatous Mitral-Valve Prolapse.
    N Engl J Med. 2019;381:e37.
    PubMed    
    
    
    
43. DE BACKER O, Dangas GD, Jilaihawi H, Leipsic JA, et al
    Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2019 Nov 16. doi: 10.1056/NEJMoa1911426.
    PubMed     Abstract available
    
    
    
44. DANGAS GD, Tijssen JGP, Wohrle J, Sondergaard L, et al
    A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2019 Nov 16. doi: 10.1056/NEJMoa1911425.
    PubMed     Abstract available
    
    
    October 2019
45. VEMULAPALLI S, Carroll JD, Mack MJ
    Volume and Outcomes for Transcatheter Aortic-Valve Replacement. Reply.
    N Engl J Med. 2019;381:1394-1395.
    PubMed    
    
    
    
46. SHARMA A
    Volume and Outcomes for Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2019;381:1394.
    PubMed    
    
    
    
47. GOLDBERG SL, Gray RM, Horne A Jr
    Volume and Outcomes for Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2019;381:1393-1394.
    PubMed    
    
    
    
48. NOBLE S, Frei A
    Volume and Outcomes for Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2019;381:1393.
    PubMed    
    
    
    
49. ACEITUNO J, Ramirez P
    Landolfi's Sign.
    N Engl J Med. 2019;381:e29.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: